APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Ablation

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Selected research

Industry Growth & Trends

Global Tumor Ablation Industry Growth and Trends Forecast to 2032

1 January 202692 pages

Choose your research edition.

Industry ResearchTumor Ablation Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Ablation Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tumor Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Ablation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Ablation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.

North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Tumor Ablation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tumor Ablation market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Ablation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Ablation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tumor Ablation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tumor Ablation Market by Company

Angiodynamics

Medtronic

Boston Scientific

Misonix

Sonacare Medical

EDAP TMS

Chongqing Haifu Medical

HealthTronics

J &J

Tumor Ablation Segment by Type

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Other Technologies

Tumor Ablation Segment by Application

Liver Cancer

Lung Cancer

Kidney Cancer

Others

Tumor Ablation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Ablation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tumor Ablation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Radiofrequency (RF) Ablation Table 2. Major Company of Microwave Ablation Table 3. Major Company of Cryoablation Table 4. Major Company of Other Technologies Table 5. Global Tumor Ablation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Tumor Ablation Sales by Type (2021-2026) & (Units) Table 7. Global Tumor Ablation Sales Market Share in Volume by Type (2021-2026) Table 8. Global Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 9. Global Tumor Ablation Sales Market Share in Value by Type (2021-2026) Table 10. Global Tumor Ablation Price by Type (2021-2026) & (USD/Unit) Table 11. Global Tumor Ablation Sales by Type (2027-2032) & (Units) Table 12. Global Tumor Ablation Sales Market Share in Volume by Type (2027-2032) Table 13. Global Tumor Ablation Sales by Type (2027-2032) & (US$ Million) Table 14. Global Tumor Ablation Sales Market Share in Value by Type (2027-2032) Table 15. Global Tumor Ablation Price by Type (2027-2032) & (USD/Unit) Table 16. North America Tumor Ablation Sales by Type (2021-2026) & (Units) Table 17. North America Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Tumor Ablation Sales by Type (2021-2026) & (Units) Table 19. Europe Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Tumor Ablation Sales by Type (2021-2026) & (Units) Table 21. Asia-Pacific Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Tumor Ablation Sales by Type (2021-2026) & (Units) Table 23. Latin America Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Tumor Ablation Sales by Type (2021-2026) & (Units) Table 25. Middle East and Africa Tumor Ablation Sales by Type (2021-2026) & (US$ Million) Table 26. Tumor Ablation Industry Trends Table 27. Tumor Ablation Industry Drivers Table 28. Tumor Ablation Industry Opportunities and Challenges Table 29. Tumor Ablation Industry Restraints Table 30. Global Tumor Ablation Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Tumor Ablation Revenue Market Share by Company (2021-2026) Table 32. Global Tumor Ablation Sales by Company (2021-2026) & (Units) Table 33. Global Tumor Ablation Sales Share by Company (2021-2026) Table 34. Global Tumor Ablation Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Tumor Ablation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Tumor Ablation Major Company Production Sites and Headquarters Table 37. Global Tumor Ablation Company, Product Type & Application Table 38. Global Tumor Ablation Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Tumor Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Tumor Ablation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Tumor Ablation Sales by Region (2021-2026) & (Units) Table 43. Global Tumor Ablation Sales Market Share in Volume by Region (2021-2026) Table 44. Global Tumor Ablation Sales by Region (2021-2026) & (US$ Million) Table 45. Global Tumor Ablation Sales Market Share in Value by Region (2021-2026) Table 46. Global Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Tumor Ablation Sales by Region (2027-2032) & (Units) Table 48. Global Tumor Ablation Sales Market Share in Volume by Region (2027-2032) Table 49. Global Tumor Ablation Sales by Region (2027-2032) & (US$ Million) Table 50. Global Tumor Ablation Sales Market Share in Value by Region (2027-2032) Table 51. Global Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Tumor Ablation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Tumor Ablation Sales by Application (2021-2026) & (Units) Table 54. Global Tumor Ablation Sales Market Share in Volume by Application (2021-2026) Table 55. Global Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 56. Global Tumor Ablation Sales Market Share in Value by Application (2021-2026) Table 57. Global Tumor Ablation Price by Application (2021-2026) & (USD/Unit) Table 58. Global Tumor Ablation Sales by Application (2027-2032) & (Units) Table 59. Global Tumor Ablation Sales Market Share in Volume by Application (2027-2032) Table 60. Global Tumor Ablation Sales by Application (2027-2032) & (US$ Million) Table 61. Global Tumor Ablation Sales Market Share in Value by Application (2027-2032) Table 62. Global Tumor Ablation Price by Application (2027-2032) & (USD/Unit) Table 63. North America Tumor Ablation Sales by Application (2021-2026) & (Units) Table 64. North America Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Tumor Ablation Sales by Application (2021-2026) & (Units) Table 66. Europe Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Tumor Ablation Sales by Application (2021-2026) & (Units) Table 68. Asia-Pacific Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Tumor Ablation Sales by Application (2021-2026) & (Units) Table 70. Latin America Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Tumor Ablation Sales by Application (2021-2026) & (Units) Table 72. Middle East and Africa Tumor Ablation Sales by Application (2021-2026) & (US$ Million) Table 73. Angiodynamics Company Information Table 74. Angiodynamics Business Overview Table 75. Angiodynamics Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Angiodynamics Tumor Ablation Product Portfolio Table 77. Angiodynamics Recent Development Table 78. Medtronic Company Information Table 79. Medtronic Business Overview Table 80. Medtronic Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Medtronic Tumor Ablation Product Portfolio Table 82. Medtronic Recent Development Table 83. Boston Scientific Company Information Table 84. Boston Scientific Business Overview Table 85. Boston Scientific Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Boston Scientific Tumor Ablation Product Portfolio Table 87. Boston Scientific Recent Development Table 88. Misonix Company Information Table 89. Misonix Business Overview Table 90. Misonix Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Misonix Tumor Ablation Product Portfolio Table 92. Misonix Recent Development Table 93. Sonacare Medical Company Information Table 94. Sonacare Medical Business Overview Table 95. Sonacare Medical Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Sonacare Medical Tumor Ablation Product Portfolio Table 97. Sonacare Medical Recent Development Table 98. EDAP TMS Company Information Table 99. EDAP TMS Business Overview Table 100. EDAP TMS Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. EDAP TMS Tumor Ablation Product Portfolio Table 102. EDAP TMS Recent Development Table 103. Chongqing Haifu Medical Company Information Table 104. Chongqing Haifu Medical Business Overview Table 105. Chongqing Haifu Medical Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Chongqing Haifu Medical Tumor Ablation Product Portfolio Table 107. Chongqing Haifu Medical Recent Development Table 108. HealthTronics Company Information Table 109. HealthTronics Business Overview Table 110. HealthTronics Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. HealthTronics Tumor Ablation Product Portfolio Table 112. HealthTronics Recent Development Table 113. J &J Company Information Table 114. J &J Business Overview Table 115. J &J Tumor Ablation Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. J &J Tumor Ablation Product Portfolio Table 117. J &J Recent Development Table 118. North America Tumor Ablation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 119. North America Tumor Ablation Sales by Country (2021-2026) & (Units) Table 120. North America Tumor Ablation Sales Market Share by Country (2021-2026) Table 121. North America Tumor Ablation Sales Forecast by Country (2027-2032) & (Units) Table 122. North America Tumor Ablation Sales Market Share Forecast by Country (2027-2032) Table 123. North America Tumor Ablation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Tumor Ablation Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Tumor Ablation Market Share by Country (2021-2026) Table 126. North America Tumor Ablation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Tumor Ablation Market Share Forecast by Country (2027-2032) Table 128. Europe Tumor Ablation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 129. Europe Tumor Ablation Sales by Country (2021-2026) & (Units) Table 130. Europe Tumor Ablation Sales Market Share by Country (2021-2026) Table 131. Europe Tumor Ablation Sales Forecast by Country (2027-2032) & (Units) Table 132. Europe Tumor Ablation Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Tumor Ablation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Tumor Ablation Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Tumor Ablation Market Share by Country (2021-2026) Table 136. Europe Tumor Ablation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Tumor Ablation Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Tumor Ablation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Tumor Ablation Sales by Country (2021-2026) & (Units) Table 140. Asia-Pacific Tumor Ablation Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Tumor Ablation Sales Forecast by Country (2027-2032) & (Units) Table 142. Asia-Pacific Tumor Ablation Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Tumor Ablation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Tumor Ablation Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Tumor Ablation Market Share by Country (2021-2026) Table 146. Asia-Pacific Tumor Ablation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Tumor Ablation Market Share Forecast by Country (2027-2032) Table 148. Latin America Tumor Ablation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 149. Latin America Tumor Ablation Sales by Country (2021-2026) & (Units) Table 150. Latin America Tumor Ablation Sales Market Share by Country (2021-2026) Table 151. Latin America Tumor Ablation Sales Forecast by Country (2027-2032) & (Units) Table 152. Latin America Tumor Ablation Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Tumor Ablation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Tumor Ablation Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Tumor Ablation Market Share by Country (2021-2026) Table 156. Latin America Tumor Ablation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Tumor Ablation Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Tumor Ablation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Tumor Ablation Sales by Country (2021-2026) & (Units) Table 160. Middle East and Africa Tumor Ablation Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Tumor Ablation Sales Forecast by Country (2027-2032) & (Units) Table 162. Middle East and Africa Tumor Ablation Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Tumor Ablation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Tumor Ablation Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Tumor Ablation Market Share by Country (2021-2026) Table 166. Middle East and Africa Tumor Ablation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Tumor Ablation Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Tumor Ablation Distributors List Table 171. Tumor Ablation Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Tumor Ablation Image Figure 2. Global Tumor Ablation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor Ablation Sales (2021-2032) & (Units) Figure 5. Radiofrequency (RF) Ablation Image Figure 6. Global Radiofrequency (RF) Ablation Sales YoY Growth (2021-2032) & (Units) Figure 7. Microwave Ablation Image Figure 8. Global Microwave Ablation Sales YoY Growth (2021-2032) & (Units) Figure 9. Cryoablation Image Figure 10. Global Cryoablation Sales YoY Growth (2021-2032) & (Units) Figure 11. Other Technologies Image Figure 12. Global Other Technologies Sales YoY Growth (2021-2032) & (Units) Figure 13. Global Tumor Ablation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Tumor Ablation Market Share by Type 2025 VS 2032 Figure 15. North America Tumor Ablation Sales Market Share in Volume by Type in 2025 Figure 16. North America Tumor Ablation Sales Market Share in Value by Type in 2025 Figure 17. Europe Tumor Ablation Sales Market Share in Volume by Type in 2025 Figure 18. Europe Tumor Ablation Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Tumor Ablation Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Tumor Ablation Sales Market Share in Value by Type in 2025 Figure 21. Latin America Tumor Ablation Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Tumor Ablation Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Tumor Ablation Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Tumor Ablation Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Tumor Ablation Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Liver Cancer Image Figure 28. Global Liver Cancer Sales YoY Growth (2021-2032) & (Units) Figure 29. Lung Cancer Image Figure 30. Global Lung Cancer Sales YoY Growth (2021-2032) & (Units) Figure 31. Kidney Cancer Image Figure 32. Global Kidney Cancer Sales YoY Growth (2021-2032) & (Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 35. Global Tumor Ablation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Tumor Ablation Market Share by Application 2025 VS 2032 Figure 37. North America Tumor Ablation Sales Market Share in Volume by Application in 2025 Figure 38. North America Tumor Ablation Sales Market Share in Value by Application in 2025 Figure 39. Europe Tumor Ablation Sales Market Share in Volume by Application in 2025 Figure 40. Europe Tumor Ablation Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Tumor Ablation Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Tumor Ablation Sales Market Share in Value by Application in 2025 Figure 43. Latin America Tumor Ablation Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Tumor Ablation Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Tumor Ablation Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Tumor Ablation Sales Market Share in Value by Application in 2025 Figure 47. North America Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. North America Tumor Ablation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Tumor Ablation Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Europe Tumor Ablation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Tumor Ablation Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Asia-Pacific Tumor Ablation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Tumor Ablation Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Latin America Tumor Ablation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Tumor Ablation Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Middle East and Africa Tumor Ablation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Tumor Ablation Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Tumor Ablation Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Tumor Ablation Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies
Applications
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Others
Companies covered
  • Angiodynamics
  • Medtronic
  • Boston Scientific
  • Misonix
  • Sonacare Medical
  • EDAP TMS
  • Chongqing Haifu Medical
  • HealthTronics
  • J &J

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tumor Ablation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tumor Ablation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tumor Ablation Market by Type
  6. 1.3.1 Radiofrequency (RF) Ablation
  7. 1.3.2 Microwave Ablation
  8. 1.3.3 Cryoablation
  9. 1.3.4 Other Technologies
  10. 1.4 Global Tumor Ablation Market Size by Type
  11. 1.4.1 Global Tumor Ablation Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Tumor Ablation Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Tumor Ablation Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Tumor Ablation Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Tumor Ablation Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Tumor Ablation Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Tumor Ablation Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Tumor Ablation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tumor Ablation Industry Trends
  2. 2.2 Tumor Ablation Industry Drivers
  3. 2.3 Tumor Ablation Industry Opportunities and Challenges
  4. 2.4 Tumor Ablation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tumor Ablation Revenue (2021-2026)
  2. 3.2 Global Top Players by Tumor Ablation Sales (2021-2026)
  3. 3.3 Global Top Players by Tumor Ablation Price (2021-2026)
  4. 3.4 Global Tumor Ablation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tumor Ablation Major Company Production Sites & Headquarters
  6. 3.6 Global Tumor Ablation Company, Product Type & Application
  7. 3.7 Global Tumor Ablation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tumor Ablation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tumor Ablation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tumor Ablation Tier 1, Tier 2, and Tier 3
4 Tumor Ablation Regional Status and Outlook
  1. 4.1 Global Tumor Ablation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tumor Ablation Historic Market Size by Region
  3. 4.2.1 Global Tumor Ablation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tumor Ablation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tumor Ablation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tumor Ablation Forecasted Market Size by Region
  7. 4.3.1 Global Tumor Ablation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tumor Ablation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tumor Ablation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tumor Ablation by Application
  1. 5.1 Tumor Ablation Market by Application
  2. 5.1.1 Liver Cancer
  3. 5.1.2 Lung Cancer
  4. 5.1.3 Kidney Cancer
  5. 5.1.4 Others
  6. 5.2 Global Tumor Ablation Market Size by Application
  7. 5.2.1 Global Tumor Ablation Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tumor Ablation Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tumor Ablation Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tumor Ablation Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tumor Ablation Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tumor Ablation Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tumor Ablation Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tumor Ablation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Angiodynamics
  2. 6.1.1 Angiodynamics Company Information
  3. 6.1.2 Angiodynamics Business Overview
  4. 6.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Angiodynamics Tumor Ablation Product Portfolio
  6. 6.1.5 Angiodynamics Recent Developments
  7. 6.2 Medtronic
  8. 6.2.1 Medtronic Company Information
  9. 6.2.2 Medtronic Business Overview
  10. 6.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Medtronic Tumor Ablation Product Portfolio
  12. 6.2.5 Medtronic Recent Developments
  13. 6.3 Boston Scientific
  14. 6.3.1 Boston Scientific Company Information
  15. 6.3.2 Boston Scientific Business Overview
  16. 6.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boston Scientific Tumor Ablation Product Portfolio
  18. 6.3.5 Boston Scientific Recent Developments
  19. 6.4 Misonix
  20. 6.4.1 Misonix Company Information
  21. 6.4.2 Misonix Business Overview
  22. 6.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Misonix Tumor Ablation Product Portfolio
  24. 6.4.5 Misonix Recent Developments
  25. 6.5 Sonacare Medical
  26. 6.5.1 Sonacare Medical Company Information
  27. 6.5.2 Sonacare Medical Business Overview
  28. 6.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sonacare Medical Tumor Ablation Product Portfolio
  30. 6.5.5 Sonacare Medical Recent Developments
  31. 6.6 EDAP TMS
  32. 6.6.1 EDAP TMS Company Information
  33. 6.6.2 EDAP TMS Business Overview
  34. 6.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 EDAP TMS Tumor Ablation Product Portfolio
  36. 6.6.5 EDAP TMS Recent Developments
  37. 6.7 Chongqing Haifu Medical
  38. 6.7.1 Chongqing Haifu Medical Company Information
  39. 6.7.2 Chongqing Haifu Medical Business Overview
  40. 6.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
  42. 6.7.5 Chongqing Haifu Medical Recent Developments
  43. 6.8 HealthTronics
  44. 6.8.1 HealthTronics Company Information
  45. 6.8.2 HealthTronics Business Overview
  46. 6.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 HealthTronics Tumor Ablation Product Portfolio
  48. 6.8.5 HealthTronics Recent Developments
  49. 6.9 J &J
  50. 6.9.1 J &J Company Information
  51. 6.9.2 J &J Business Overview
  52. 6.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 J &J Tumor Ablation Product Portfolio
  54. 6.9.5 J &J Recent Developments
7 North America by Country
  1. 7.1 North America Tumor Ablation Sales by Country
  2. 7.1.1 North America Tumor Ablation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tumor Ablation Sales by Country (2021-2026)
  4. 7.1.3 North America Tumor Ablation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tumor Ablation Market Size by Country
  6. 7.2.1 North America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tumor Ablation Market Size by Country (2021-2026)
  8. 7.2.3 North America Tumor Ablation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tumor Ablation Sales by Country
  2. 8.1.1 Europe Tumor Ablation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tumor Ablation Sales by Country (2021-2026)
  4. 8.1.3 Europe Tumor Ablation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tumor Ablation Market Size by Country
  6. 8.2.1 Europe Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tumor Ablation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tumor Ablation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tumor Ablation Sales by Country
  2. 9.1.1 Asia-Pacific Tumor Ablation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tumor Ablation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tumor Ablation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tumor Ablation Market Size by Country
  6. 9.2.1 Asia-Pacific Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tumor Ablation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tumor Ablation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tumor Ablation Sales by Country
  2. 10.1.1 South America Tumor Ablation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tumor Ablation Sales by Country (2021-2026)
  4. 10.1.3 South America Tumor Ablation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tumor Ablation Market Size by Country
  6. 10.2.1 South America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tumor Ablation Market Size by Country (2021-2026)
  8. 10.2.3 South America Tumor Ablation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tumor Ablation Sales by Country
  2. 11.1.1 Middle East and Africa Tumor Ablation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tumor Ablation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tumor Ablation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tumor Ablation Market Size by Country
  6. 11.2.1 Middle East and Africa Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tumor Ablation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tumor Ablation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tumor Ablation Value Chain Analysis
  2. 12.1.1 Tumor Ablation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tumor Ablation Production Mode & Process
  7. 12.2 Tumor Ablation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tumor Ablation Distributors
  10. 12.2.3 Tumor Ablation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst